MedTrace Logo

Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation

NCT00816101 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2011-03-09

Study results available
· View outcomes & findings →

Summary

The purpose of this pilot clinical study is to compare healing rates, pain levels, and incidence of wound complications including infection with the use of a moist PROCELLERA™ Antimicrobial Wound Dressing when compared to a standard dressing, Mepilex® Border Lite, following curettage and electrodesiccation of skin lesions.

Conditions

  • Acute Wounds

Interventions

OTHER

Procellera™ Antimicrobial Dressing

Dressing indicated for partial and full-thickness wounds.

OTHER

Mepilex® Border Lite

Self-adherent foam dressing

DEVICE

Adhesive Bandage

Adhesive bandage

Sponsors & Collaborators

  • Vomaris Innovations

    lead INDUSTRY

Principal Investigators

  • Scott N Sheftel, MD · Sheftel Associates Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-09-30
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00816101 on ClinicalTrials.gov